Childhood Cancer, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Conditions
Brief summary
This clinical trial studies the effectiveness of a newly developed survivorship mobile application (app) designed for survivors, or their caregivers, of childhood cancer to help them better navigate long-term follow-up care. The survivorship app provides survivors access to their treatment history and follow-up recommendations, improves knowledge of their diagnosis, treatment, risks, and recommended follow-up care by using a message notification. The ability to quickly connect and establish care planning may enhance adherence to recommended follow-up.
Detailed description
PRIMARY OBJECTIVE: I. To determine the difference in survivor/caregiver knowledge and understanding of diagnosis, treatment information, and follow-up needs using the survivorship app. SECONDARY OBJECTIVE: I. To validate the usability and effectiveness of the survivorship mobile application. OUTLINE: Participants are seen in the survivorship clinic and receive education about potential late effects and the survivorship application on study. Participants then use the survivorship app for 4 months on study.
Interventions
BEHAVIORALSurvivorship mobile application
Mobile phone application
OTHERQuestionnaires
Questionnaires assessing cancer knowledge and system usability will be delivered to participants via Survivorship App
Sponsors
University of California, San Francisco
Swim Across America
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Healthy volunteers
Yes
Inclusion criteria
* Survivors of childhood cancer attending Survivorship Clinic at University of California, San Francisco (UCSF) OR caregivers of a childhood cancer survivor attending Survivorship Clinic at UCSF. * Must have a mobile device (smartphone or smart-tablet) with service plan. * Must have ability to read, write, and understand English language.
Exclusion criteria
* An individual who does not meet any of the criteria mentioned above will be excluded from participation in this study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in knowledge questionnaire score | Up to 4 months | The knowledge of the participant will be measured using a 12-item questionnaire that assesses the awareness of their treatment and health issues in four categories: (1) diagnosis, (2) treatment, (3) risks, and (4) recommended follow-up. A scoring system has been devised which will give a score to each questionnaire out of 100 possible points. The change in participants knowledge scores \>=20 points from baseline will be reported. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| System usability scale (SUS) score > 68 | Up to 2 months | System Usability Scale (SUS) consists of a 10-item survey with five response options from Strongly agree to Strongly disagree. The scoring of positive questions is done as follows: The user's score is reduced by one point. For example, if the user's score is 4 for question 5, then the outcome score will be 3. The scoring of negative questions is done as follows: The user's score is subtracted from 5. For example, if the user's score is 3 for question 4, then the new score will be 2. After all the scores are determined, the sum of the scores is multiplied by 2.5 to make the range between 0 and 100. Scores above 68 are considered above average. The proportion of participants with an acceptable usability score \> 68 will be reported. |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORRobert Goldsby, MD
University of California, San Francisco
Outcome results
None listed